Valo SPAC Presentation Deck
The pharmaceutical industry is at an inflection point: the scale of human
centric data and computation now enables a step change¹
PHARMACEUTICAL INDUSTRY TRENDS
Decreasing R&D productivity³
Increasing pricing pressures³
Point-to-point system4
Divergent stakeholders5
$1.25T
Biopharmaceutical
worldwide industry
revenue²
THE VALO OPPORTUNITY
Data & computation designed
to increase precision, and
reduce cost and time
Scalable, capital efficient
platform designed to provide
sustainable value creation
Unified and integrated to
provide continuous
improvement
Aligned patient, market and
development needs
[1] Steedman, Mark., et al. "Intelligent Biopharma: Forging the Links Across the Vale Chain." Deloitte Insights, Deloitte Center for Health Solutions, (Oct 2019)
[2] Global pharmaceutical industry, Statista (Accessed April 20, 2021)
[3]
Deloitte. "Ten years on: Measuring the Return from Pharmaceutical Innovation 2019." Deloitte Center for Healthcare Solutions, (2019)
Valo [4] Konersmann, Todd., et al. "Innovating R&D with the Cloud: Business Transformation Could Require Cloud-Enabled Ecosystems, and Services." Deloitte Insights, Deloitte Center for Health Solutions, (Dec 2020)
[5] Peter Kolchinsky, The Great American Drug Deal: A New Prescription for Innovative and Affordable Medicines, Ch 1. (Evelexa Press, 2020)
2Q21
9View entire presentation